Crossmark

Strategies for improving treatment retention for buprenorphine/naloxone for opioid use disorder: a qualitative study of issues and recommendations from prescribers

Crossref DOI link: https://doi.org/10.1186/s13722-024-00516-z

Published Online: 2024-11-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Young, Gary J.

Young, Leonard D.

Noor-E-Alam, Md. https://orcid.org/0000-0001-5353-9710
Funding

Funding for this research was provided by:

Northeastern University USA
License Information

Text and Data Mining valid from 2024-11-21

Version of Record valid from 2024-11-21
More Information

Article History

Received: 11 December 2023

Accepted: 7 October 2024

First Online: 21 November 2024

Declarations

:

: Approval was secured from a Northeastern University Institutional Review Board (IRB 19-05-06) and consent was obtained from all study participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below